Cargando…
Need for strict clinical management of patients with carnitine palmitoyltransferase II deficiency: Experience with two cases detected by expanded newborn screening
In Japan, carnitine palmitoyltransferase II (CPTII) deficiency has been included as one of the primary target diseases in the expanded newborn mass screening program since 2018. However, many cases of the severe infantile hepatocardiomuscular form of CPTII deficiency showed severe neurodevelopmental...
Autores principales: | Bo, Ryosuke, Musha, Ikuma, Yamada, Kenji, Kobayashi, Hironori, Hasegawa, Yuki, Awano, Hiroyuki, Arao, Masato, Kikuchi, Toru, Taketani, Takeshi, Ohtake, Akira, Yamaguchi, Seiji, Iijima, Kazumoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260588/ https://www.ncbi.nlm.nih.gov/pubmed/32489884 http://dx.doi.org/10.1016/j.ymgmr.2020.100611 |
Ejemplares similares
-
A newborn case with carnitine palmitoyltransferase II deficiency initially judged as unaffected by acylcarnitine analysis soon after birth
por: Yamada, Kenji, et al.
Publicado: (2017) -
False positive cases of elevated tetradecenoyl carnitine in newborn mass screening showed significant loss of body weight
por: Bo, Ryosuke, et al.
Publicado: (2020) -
Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
por: Glauber, Violeta, et al.
Publicado: (2014) -
Severe rhabdomyolysis in homozygote carnitine palmitoyltransferase II deficiency
por: Schnedl, Wolfgang J., et al.
Publicado: (2020) -
Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II
por: Motlagh, Leila, et al.
Publicado: (2016)